ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026
Development of a rapid diagnostic test for the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus: Cefinase disk direct (CDD) test.
Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCefazolin is one of the first-line treatment for methicillin-susceptible Staphylococcus aureus (MSSA) infections worldwide. However, the cefazolin inoculum effect (CInE) can compromise its therapeutic efficacy, and the development of a rapid, practical diagnostic method to identify CInE-positive MSSA isolates is urgently required.
objectivesTo develop the novel Cefinase Disk Direct (CDD) test and evaluate its diagnostic performance.
methodsA total of 370 clinical MSSA isolates obtained from blood cultures across three Japanese hospitals were evaluated. CInE was determined by comparing MICs under standard and high-inoculum conditions. As a standardized alternative to the nitrocefin powder utilized in previous methods, we employed Cefinase disks for visual colorimetric detection. To validate diagnostic accuracy, we compared results obtained using direct inoculation (loopful) versus optical density (OD)-adjusted bacterial suspensions.
resultsOf all, 110 (29.7%) harbored the blaZ gene and 4 (1.1%) exhibited CInE; all CInE-positive strains were identified as blaZ type A. The CDD test demonstrated sensitivity of 100%, specificity of 94.4% (OD-adjusted) to 99.7% (loopful), positive predictive value of 80.0%, and negative predictive value of 100%. The spectrophotometric analysis resulted in sensitivity of 100%, specificity of 83.3%, and positive predictive value of 80.0%. The CDD test shortens the turnaround time to just 1.5 h.
conclusionsThe proposed CDD test demonstrated satisfactory diagnostic performance for the detection of blaZ type A-harboring MSSA isolates. Further optimization is warranted to ensure that the assay becomes a rapid, cost-effective, and easily implementable solution for hospital laboratories worldwide.
Indexed as
Identifiers
42742920What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.